Encompass Test

About Mirvie

Mirvie is a private, pre-revenue diagnostics company pioneering a predictive RNA platform for pregnancy complications. Its core technology uses machine learning to analyze cell-free RNA signals from the mother, placenta, and fetus, enabling early risk assessment for conditions like preeclampsia. The company's lead product, the Encompass Test for preeclampsia prediction, has garnered recognition and is supported by landmark peer-reviewed research. Mirvie aims to address the significant unmet need in maternal-fetal health, where one in five pregnancies is affected by complications.

Therapeutic Areas